Metformin Hydrochloride in Treating Women With Stage I or Stage II Breast Cancer That Can Be Removed By Surgery

Stopped early · Not applicable

Conditions studied: Breast Cancer

In brief

RATIONALE: Metformin hydrochloride may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. PURPOSE: This phase I trial is studying how well metformin hydrochloride works in treating women with stage I or stage II breast cancer that can be removed by surgery.

Key facts

Study ID

NCT00984490

Run by

Vanderbilt-Ingram Cancer Center

People needed

5

Starts

2009-09-01

Expected to finish

2011-07-01

Last updated by the study team

2024-02-01

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

Where it is running

• Emory University Hospital — Atlanta, Georgia, United States
• Vanderbilt-Ingram Cancer Center - Cool Springs — Nashville, Tennessee, United States
• Vanderbilt-Ingram Cancer Center — Nashville, Tennessee, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.